#biotechnology - Techseriesinsight

March 24, 2025
PRNewswire
Biotechnology

Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress

Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment of recurrence of Dupuytren contracture following surgical correction will...

March 21, 2025
PRNewswire
Biotechnology

Nanomi Receives CMO Award for Life Science Leadership in Drug Delivery

Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery,...

March 21, 2025
PRNewswire
Biotechnology

The Galien Foundation Honors 2025 Modi Prix Galien India Award Recipients

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, celebrated excellence and innovation in life sciences during the Prix Galien India Forum and second...

March 20, 2025
PRNewswire
Biotechnology

iOnctura commences randomized Phase II study in metastatic uveal melanoma

iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in the randomized Phase II OCULE-01 study investigating lead asset roginolisib...

March 20, 2025
PRNewswire
Biotechnology

Caris Life Sciences Publishes Study Featuring the Largest Real-World Cohort of Tissue-Agnostic Indications Revealing Over 20 Percent of Patients Are Eligible for “Pan-Cancer” Therapies

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced the publication of “Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals” in Nature Communications....

March 18, 2025
PRNewswire
Biotechnology

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational...

March 13, 2025
PRNewswire
Biotechnology

Registration Now Open for World Vaccine Congress Washington 2025: Leading Experts from Government, WHO, CEPI, and more to Speak

The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open for registration. Taking place from April 21-24, 2025, at the Walter E....

March 12, 2025
PRNewswire
Biotechnology

Vivace Therapeutics Raises $35 Million in Series D Financing to Support Clinical Development of First-in-Class Cancer Drug Targeting the Hippo Pathway

Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, today announced the closing of a $35 million Series D financing. The round...

March 11, 2025
PRNewswire
Biotechnology

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025

Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, is highlighting its latest advancements in digital orthopaedics at the American Academy of Orthopaedic Surgeons (AAOS) 2025...